Skip to Main Content

Author Details

Rut Klinger
UCD Conway Institute, University College Dublin
2006
15
11
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34090143Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors.Eur J Cancer2021
32555399Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer.Sci Rep2020
29069577Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.Cancer Lett2018
30291241Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy.Nat Commun2018
29792754Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab.J Clin Oncol2018
29243812Dysregulated mitogen-activated protein kinase signalling as an oncogenic basis for clear cell sarcoma of the kidney.J Pathol2018
28611295Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach.Oncotarget2017
28487489Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer.Oncotarget2017
28455421Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer.Cancer Res2017
28213567Vitamin D receptor as a target for breast cancer therapy.Endocr Relat Cancer2017
25626736Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesity.Diabetes2015
24649821microRNAs: a new class of breast cancer biomarkers.Expert Rev Mol Diagn2014
25379014Dynamic and influential interaction of cancer cells with normal epithelial cells in 3D culture.Cancer Cell Int2014
21677534SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.Am J Surg Pathol2011
16849521Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells.Mol Cancer Res2006
  • 1 - 15 of 15

Recommended Authors

Juan Moreno
University of Toronto
Career Start Year 2011
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Patrick C O'Leary
University of California San Francisco
Career Start Year 2010
Number of shared co-authors 9
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 5
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 0
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 1
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 1
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 0
Alejandra Bruna
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2002
Number of shared co-authors 2
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 0
Euan A Stronach
Imperial College London
Career Start Year 1999
Number of shared co-authors 0
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 8
Francesca M Buffa
University of Oxford
Career Start Year 1998
Number of shared co-authors 0
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 3
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 4
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 1
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 1
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 0
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 5
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 1

Collaborators

Darran P O'Connor
UCD Conway Institute, University College Dublin
Co-authored papers 14
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 11
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Co-authored papers 5
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Co-authored papers 5
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Co-authored papers 5
Diether Lambrechts
Co-authored papers 4
Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers 2
Karin Jirstr??m
Lund University
Co-authored papers 2
Sharon F McGee
The Ottawa Hospital Cancer Centre
Co-authored papers 2
Louis Banka Johnson
Skane University Hospital - Malmo, Lund University
Co-authored papers 1
Sami Kilpinen
University of Helsinki
Co-authored papers 1
Marcus Gry
AlbaNova University Center, KTH Royal Institute of Technology
Co-authored papers 1
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 1
Eric J T Belt
Albert Schweitzer Hospital
Co-authored papers 1
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 1
Adrian P Bracken
Smurfit Institute of Genetics, Trinity College Dublin
Co-authored papers 1
Helen M Roche
UCD Conway Institute, School of Public Health, University College Dublin
Co-authored papers 1
Anna Asplund
Uppsala University
Co-authored papers 1
Caroline Kampf
Uppsala University
Co-authored papers 1
Elton Rexhepaj
UCD Conway Institute, University College Dublin
Co-authored papers 1
Karsten Hokamp
Smurfit Institute of Genetics, Trinity College of Dublin
Co-authored papers 1
Kristina Magnusson
Uppsala University
Co-authored papers 1
Helgi Birgisson
The Icelandic Cancer Registry
Co-authored papers 1
Kirsha Naicker
Co-authored papers 1
Gillian O'Hurley
OncoMark Ltd
Co-authored papers 1
Jeroen A C M Goos
Karolinska Institutet
Co-authored papers 1
Olli Kallioniemi
Karolinska Institute
Co-authored papers 1
Kenneth Wester
Uppsala University
Co-authored papers 1
Sanjay Navani
Breach Candy Hospital and Research Centre
Co-authored papers 1
Carl A K Borrebaeck
Lund University
Co-authored papers 1
Release 1.2